Noticias de EXAS_US

Noticias del mercado

Últimas noticias sobre EXAS_US — 50 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: EXAS_US ✕ 50 resultados
22/04/2026 EXAS_US — Quartr
Exact Sciences (EXAS) Proxy Filing Summary
20/04/2026 EXAS_US — DirectorsTalk Interviews
Exact Sciences Corporation (EXAS) Investor Outlook: Analyzing the Growth Potential and Analyst Consensus
18/04/2026 EXAS_US — MSN
Exact Sciences climbs on full year guidance raise, revenue beat
17/04/2026 EXAS_US — Abbott MediaRoom
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
17/04/2026 EXAS_US — Stock Titan ES ← EN
Abbott dice que un análisis de sangre con dos biomarcadores mejora la detección temprana del cáncer
16/04/2026 EXAS_US — Reuters
Exact Sciences Corporation
02/04/2026 EXAS_US — Stock Titan
Exact Sciences (NASDAQ: EXAS) files Form 15 to suspend certain SEC reporting duties
24/03/2026 EXAS_US — marketscreener.com
Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Biotechnology Select Industry Index
23/03/2026 EXAS_US — Stock Titan
Exact Sciences (EXAS) director has equity cancelled and cashed out at $105 per share in Abbott merger
23/03/2026 EXAS_US — Stock Titan
Abbott deal converts Exact Sciences (EXAS) GC Herriott’s stock, options and RSUs
23/03/2026 EXAS_US — Investing.com
Abbott completes $21 billion acquisition of Exact Sciences, delisting EXAS from Nasdaq
23/03/2026 EXAS_US — Stock Titan
Abbott (NYSE: ABT) closes Exact Sciences cancer diagnostics deal
23/03/2026 EXAS_US — Stock Titan
Abbott buys Exact Sciences (NASDAQ: EXAS) in $21B cash deal
23/03/2026 EXAS_US — Stock Titan
Executive equity overhauled as Exact Sciences (EXAS) completes Abbott cash merger
23/03/2026 EXAS_US — Stock Titan
Abbott buys Exact Sciences (NASDAQ: EXAS) in $105-per-share cash merger
23/03/2026 EXAS_US — Stock Titan
Abbott acquires Exact Sciences (NASDAQ: EXAS) in $105-per-share cash deal
23/03/2026 EXAS_US — Stock Titan
Abbott deal: Exact Sciences (EXAS) CEO equity cashed out or converted
23/03/2026 EXAS_US — Stock Titan
Abbott’s buyout of Exact Sciences (EXAS) cashes out director’s shares
23/03/2026 EXAS_US — Stock Titan
[Form 4] EXACT SCIENCES CORP Insider Trading Activity
23/03/2026 EXAS_US — Stock Titan
Abbott-Exact Sciences (EXAS) deal cashes exec equity at $105 per share

Página 1 de 3

keyboard_arrow_up